(Q51721666)

10 April 2018

title

Breast Cancer OncoGuia. (English)

1 reference

10 April 2018

author

Algara M

1 reference

ORCID Public Data File 2021

author name string

Paula Manchon

1

1 reference

10 April 2018

Josep M Borràs

2

1 reference

10 April 2018

Tàrsila Ferro

3

1 reference

10 April 2018

Josep Alfons Espinàs

4

1 reference

10 April 2018

Breast Cancer OncoGuia Group

5

1 reference

10 April 2018

publication date

1 February 2010

1 reference

10 April 2018

Clinical and Translational Oncology

published in

1 reference

10 April 2018

volume

12

1 reference

10 April 2018

issue

2

1 reference

10 April 2018

page(s)

113-138

1 reference

10 April 2018

Practical solutions to common mammographic problems: tailoring the examination

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0477-9

Medical audit of a rapid-throughput mammography screening practice: methodology and results of 27,114 examinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0477-9

Usefulness of mammography and sonography in women less than 35 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0477-9

Ductography: how to and what if?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0477-9

Percutaneous large-core breast biopsy: a multi-institutional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0477-9

MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0477-9

Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0477-9

Sentinel lymph node mapping for breast cancer: analysis in a diverse patient group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0477-9

Learning sentinel node biopsy: results of a prospective randomized trial of two techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0477-9

Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19-22, 2001, Philadelphia, PA, USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0477-9

A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0477-9

Concurrent CMF and radiation therapy for early stage breast cancer: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0477-9

Concurrent radiotherapy does not affect adjuvant CMF delivery but is associated with increased toxicity in women with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0477-9

The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0477-9

American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines.

21 January 2018

1 reference

12 December 2020

Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study

1 reference

12 December 2020

Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials

1 reference

12 December 2020

Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial

1 reference

12 December 2020

Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.

1 reference

12 December 2020

Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy

1 reference

12 December 2020

[2006 technology monitoring report: clinical practice guideline: use of FDG-PET in kidney, prostate, testis and bladder cancers].

1 reference

12 December 2020

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

1 reference

12 December 2020

Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography

1 reference

12 December 2020

Lymphatic Mapping and Sentinel Lymph Node Biopsy

1 reference

12 December 2020

The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer.

1 reference

12 December 2020

MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer

1 reference

12 December 2020

Specificity of mammography and US in the evaluation of a palpable abnormality: retrospective review

1 reference

12 December 2020

Imaging breast cancer

1 reference

12 December 2020

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

1 reference

12 December 2020

The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy

1 reference

12 December 2020

Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients.

1 reference

12 December 2020

Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: a systematic review

1 reference

12 December 2020

Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network

1 reference

12 December 2020

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

12 December 2020

Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results

1 reference

12 December 2020

High risk of breast carcinoma after irradiation of young women with Hodgkin's disease

1 reference

12 December 2020

Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 r

1 reference

12 December 2020

Stereotactic core-needle biopsy of the breast: a report of the Joint Task Force of the American College of Radiology, American College of Surgeons, and College of American Pathologists.

1 reference

12 December 2020

Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual

1 reference

12 December 2020

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

12 December 2020

Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996

1 reference

12 December 2020

Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer

1 reference

12 December 2020

Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial

1 reference

12 December 2020

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

12 December 2020

[Consensus meeting on selective biopsy of the sentinel node in breast cancer. Spanish Society of Senology and Breast Disease]

1 reference

12 December 2020

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

1 reference

12 December 2020

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Cli

1 reference

12 December 2020

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study

1 reference

12 December 2020

Breast reconstruction using perforator flaps

1 reference

12 December 2020

Breast cancer and other second neoplasms after childhood Hodgkin's disease

1 reference

12 December 2020

Guidelines from the European Society of Breast Imaging for diagnostic interventional breast procedures

1 reference

12 December 2020

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

1 reference

12 December 2020

Utility of cytologic specimens in the evaluation of prognostic and predictive factors of breast cancer: current issues and future directions

1 reference

12 December 2020

Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials

1 reference

12 December 2020

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22

1 reference

12 December 2020

Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

12 December 2020

Distinct lymph nodal sonographic characteristics in breast cancer patients at high risk for axillary metastases correlate with the final axillary stage

1 reference

12 December 2020

Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

1 reference

12 December 2020

An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens

1 reference

12 December 2020

Adjuvant docetaxel for node-positive breast cancer

1 reference

12 December 2020

Predictive value of galactographic patterns for benign and malignant neoplasms of the breast in patients with nipple discharge

1 reference

12 December 2020

Ten-year results of FAC adjuvant chemotherapy trial in breast cancer

1 reference

12 December 2020

Timing of radiotherapy in breast cancer conserving treatment

1 reference

12 December 2020

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

12 December 2020

Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back?

1 reference

12 December 2020

MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results

1 reference

12 December 2020

HER2 as a prognostic and predictive marker for breast cancer

1 reference

12 December 2020

Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment

1 reference

12 December 2020

Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: The G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly

1 reference

12 December 2020

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group

1 reference

12 December 2020

Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay

1 reference

12 December 2020

Conservative surgery and chemotherapy for breast carcinoma during pregnancy

1 reference

12 December 2020

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results

1 reference

12 December 2020

Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers

1 reference

12 December 2020

Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors.

1 reference

12 December 2020

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Gro

1 reference

12 December 2020

Breast MRI: guidelines from the European Society of Breast Imaging.

1 reference

12 December 2020

Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?

1 reference

12 December 2020

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

1 reference

12 December 2020

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

1 reference

12 December 2020

Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment

1 reference

12 December 2020

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

1 reference

12 December 2020

Role of MRI in screening, diagnosis and management of breast cancer

1 reference

12 December 2020

Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer

1 reference

12 December 2020

Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging

1 reference

12 December 2020

Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer

1 reference

12 December 2020

Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group

1 reference

12 December 2020

Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study.

1 reference

12 December 2020

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm

1 reference

12 December 2020

Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial

1 reference

12 December 2020

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

1 reference

12 December 2020

Prediction of breast tumor size by mammography and sonography--A breast screen experience

1 reference

12 December 2020

Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence?

1 reference

12 December 2020

Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882.

1 reference

12 December 2020

The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy

1 reference

12 December 2020

Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself*.

1 reference

12 December 2020

Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

1 reference

12 December 2020

Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.

1 reference

12 December 2020

Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer.

1 reference

12 December 2020

Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

1 reference

12 December 2020

Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience

1 reference

12 December 2020

Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28.

1 reference

12 December 2020

Chemotherapy and concomitant irradiation in inflammatory breast cancer.

1 reference

12 December 2020

Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer

1 reference

12 December 2020

Risk factors of local relapse in breast cancer: the importance of age

1 reference

12 December 2020

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group

1 reference

12 December 2020

Usefulness of the triple test score for palpable breast masses; discussion 1012-3

1 reference

12 December 2020

Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients. a prospective, comparative, non-randomised study

1 reference

12 December 2020

Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast canc

1 reference

12 December 2020

A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma: final analysis with 10-year follow-up

1 reference

12 December 2020

Suggestions for HER-2/neu testing in breast carcinoma, based on a comparison of immunohistochemistry and fluorescence in situ hybridisation

1 reference

12 December 2020

Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer.

1 reference

12 December 2020

Who should have breast magnetic resonance imaging evaluation?

1 reference

12 December 2020

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

1 reference

12 December 2020

Evaluation of common breast problems: guidance for primary care providers

1 reference

12 December 2020

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer.

1 reference

12 December 2020

State of the art of current modalities for the diagnosis of breast lesions

1 reference

12 December 2020

Magnetic resonance evaluation of the presence of an extensive intraductal component in breast cancer

1 reference

12 December 2020

Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

12 December 2020

Effect of screening and adjuvant therapy on mortality from breast cancer

1 reference

12 December 2020

Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.

1 reference

12 December 2020

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

12 December 2020

Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up

1 reference

12 December 2020

Factors predictive of response to hormone therapy in breast cancer.

1 reference

12 December 2020

Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials

1 reference

12 December 2020

Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB Trial).

1 reference

12 December 2020

HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer

1 reference

12 December 2020

Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.

1 reference

12 December 2020

Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging.

1 reference

12 December 2020

Locally advanced breast cancer: is surgery necessary?

1 reference

12 December 2020

Lymphatic mapping in breast cancer: combination technique

1 reference

12 December 2020

Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up

1 reference

12 December 2020

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease

1 reference

12 December 2020

Clinical practice guidelines for cancer care: what are they for?

1 reference

12 December 2020

Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review

1 reference

12 December 2020

MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound

1 reference

12 December 2020

Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

1 reference

12 December 2020

Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial

1 reference

12 December 2020

The influence of margin width on local control of ductal carcinoma in situ of the breast

1 reference

12 December 2020

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

12 December 2020

Highlights from recent National Surgical Adjuvant Breast and Bowel Project studies in the treatment and prevention of breast cancer

1 reference

12 December 2020

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

1 reference

12 December 2020

[Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985-2019: Breast cancer]

1 reference

12 December 2020

Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.

1 reference

12 December 2020

Pattern of lymphatic drainage to the sentinel lymph node in breast cancer patients.

1 reference

12 December 2020

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

1 reference

12 December 2020

Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators

1 reference

12 December 2020

Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.

1 reference

12 December 2020

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

1 reference

12 December 2020

Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer

1 reference

12 December 2020

Effect of delay in radiation in the combined modality treatment of breast cancer

1 reference

12 December 2020

Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma.

1 reference

12 December 2020

Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection

1 reference

12 December 2020

A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer

1 reference

12 December 2020

The sentinel node in breast cancer--a multicenter validation study

1 reference

12 December 2020

Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women

1 reference

12 December 2020

The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients.

1 reference

12 December 2020

Learning curves and breast cancer lymphatic mapping: institutional volume index.

1 reference

12 December 2020

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results

1 reference

12 December 2020

Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma

1 reference

12 December 2020

Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?

1 reference

12 December 2020

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).

1 reference

12 December 2020

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

1 reference

12 December 2020

Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures.

1 reference

12 December 2020

Fine needle aspiration for evaluation of breast masses

1 reference

12 December 2020

Ultrasound-guided fine-needle aspiration of clinically negative lymph nodes versus sentinel node mapping in patients at high risk for axillary metastasis

1 reference

12 December 2020

Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer.

1 reference

12 December 2020

The role of mammography in women under 30.

1 reference

12 December 2020

Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up.

1 reference

12 December 2020

Time trends of breast cancer mortality in Spain during the period 1977-2001 and Bayesian approach for projections during 2002-2016.

1 reference

12 December 2020

A randomized trial of surgery in the treatment of single metastases to the brain.

1 reference

12 December 2020

Sonography of palpable breast cancer

1 reference

12 December 2020

Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer

1 reference

12 December 2020

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group

1 reference

12 December 2020

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

1 reference

12 December 2020

10.1007/S12094-010-0477-9

Identifiers

DOI

1 reference

10 April 2018

1 reference

10 April 2018